Related Experiment Videos
[Effects of nitroglycerin on the graft flow during aortocoronary bypass surgery]
Insights
Intravenous nitroglycerin improved coronary artery bypass graft flow, particularly diastolic flow, in patients undergoing surgery. Higher doses decreased blood pressure but preserved diastolic flow, suggesting nitroglycerin safely relieves myocardial ischemia.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Pharmacology
Background:
- Coronary artery bypass graft (CABG) surgery requires careful hemodynamic management.
- Nitroglycerin is a vasodilator used to manage cardiovascular conditions.
Observation:
- The study investigated intravenous nitroglycerin's effects on hemodynamics and bypass graft flow in 16 CABG patients.
- Doses of 0.2 mcg/kg/min did not alter systolic blood pressure, cardiac output, or left ventricular minute work.
- This low dose significantly increased graft flow volume, especially diastolic flow, altering flow velocity waveforms.
Findings:
- A higher dose of 1 mcg/kg/min caused significant reductions in systolic blood pressure, cardiac output, and overall graft flow.
- Despite the decrease in cardiac output and left ventricular minute work, diastolic graft flow was maintained at the higher dose.
- Nitroglycerin administration resulted in a more diastolic-predominant flow pattern in the grafts.
Implications:
- Intravenous nitroglycerin can be safely administered during CABG surgery.
- Nitroglycerin may improve the balance between myocardial oxygen supply and demand.
- The drug shows potential for relieving myocardial ischemia in the context of coronary artery surgery.
Abstract:
The effects of an intravenous infusion of nitroglycerin on the hemodynamics and bypass graft flow to left coronary artery were studied in sixteen patients during coronary artery surgery. Systolic blood pressure, cardiac output and left ventricular minute work were not affected by 0.2 microgram/kg/min of nitroglycerin but graft flow volume especially diastolic graft flow increased significantly and the characteristics of flow velocity waveform in the graft became more diastolic predominant. By 1 microgram/kg/min of nitroglycerin a significant decrease in systolic blood pressure, cardiac output and graft flow were recognized, however diastolic graft flow was preserved despite of a decrease in left ventricular minute work. These findings demonstrate that nitroglycerin can be safely administered intravenously during aortocoronary bypass surgery, and suggest that nitroglycerin improves the balance of myocardial oxygen demand and supply, and relieves myocardial ischemia.